APA (7th ed.) Citation

Johnson, K., Brooks, B., Ford, C., Goodman, A., Lisak, R., Myers, L., . . . Wolinsky, J. (2003). Glatiramer acetate (Copaxone): Comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial. Multiple Sclerosis (13524585), 9(6), 585. https://doi.org/10.1191/1352458503ms961oa

Chicago Style (17th ed.) Citation

Johnson, KP, et al. "Glatiramer Acetate (Copaxone): Comparison of Continuous Versus Delayed Therapy in a Six-year Organized Multiple Sclerosis Trial." Multiple Sclerosis (13524585) 9, no. 6 (2003): 585. https://doi.org/10.1191/1352458503ms961oa.

MLA (9th ed.) Citation

Johnson, KP, et al. "Glatiramer Acetate (Copaxone): Comparison of Continuous Versus Delayed Therapy in a Six-year Organized Multiple Sclerosis Trial." Multiple Sclerosis (13524585), vol. 9, no. 6, 2003, p. 585, https://doi.org/10.1191/1352458503ms961oa.